Clinical Trials Directory

Trials / Unknown

UnknownNCT05580198

Prognostic Markers of Post-Stroke Depression (PROMoSD)

Prognostic Markers of Post-Stroke Depression: A Single-center Prospective Observational Study

Status
Unknown
Phase
Study type
Observational
Enrollment
105 (estimated)
Sponsor
Ruhr University of Bochum · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Single-center prospective observational study investigating the association of brainstem raphe hypoechogenicity detected by transcranial sonography and post-stroke depression three months after an acute ischemic stroke.

Detailed description

Post-stroke depression (PSD) is an important complication after a stroke. Despite significant limitations between studies of PSD risk factors, stroke severity or post-stroke disability, prior depressive episodes, and female sex are arguably the most well-known risk factors for developing PSD, although the predictive value of these factors is limited. A hypoechogenic brainstem raphe (BR) detected by transcranial sonography (TCS) is associated with depressive symptoms in distinct diseases but is also common with approximately 25% of the non-depressed population in Europe. The primary aim of this study is to investigate the association between BR hypoechogenicity and PSD occurrence in a prospective observational study design.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTTranscranial sonography.Transcranial sonography examination to determine the brainstem raphe echogenicity.

Timeline

Start date
2021-01-01
Primary completion
2022-11-01
Completion
2023-03-01
First posted
2022-10-14
Last updated
2022-10-17

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05580198. Inclusion in this directory is not an endorsement.